AGREEMENT OF LEASE Between ZAPCO 1500 INVESTMENT, L.P., Landlord, and NUVATION BIO, INC. Tenant. PREMISES: Portion of the Fourteenth (14th) Floor 1500 Broadway New York, New York Lease Date: June 30th, 2019Lease Agreement • December 18th, 2020 • Panacea Acquisition Corp • Pharmaceutical preparations • New York
AGREEMENT OF LEASE (this “Lease”), made as of this 30th day of June, 2019, between ZAPCO 1500 INVESTMENT, L.P., a Delaware limited partnership, having an office at do Tamares Real Estate Holdings, Inc., 24th floor, Times Square Plaza, 1500 Broadway, New York, New York 10036 (hereinafter called, the “Landlord”) and NUVATION BIO, INC., a Delaware corporation, having its principal office at [Address] (hereinafter called, the “Tenant”).
ASSET ACQUISITION AGREEMENTAsset Acquisition Agreement • December 18th, 2020 • Panacea Acquisition Corp • Pharmaceutical preparations • Delaware
THIS ASSET ACQUISITION AGREEMENT (the “Agreement”) is made and entered into as of January 21, 2019, by and between: REPHARMATION INC., a Delaware corporation (“Acquiror”); GIRAFPHARMA LLC, a Delaware limited liability company (“Transferor”); and David Hung (“Founder”). Capitalized terms used but not otherwise defined in this Agreement are defined in Exhibit A. Each of Acquiror and Transferor is referred to individually as a “party” and collectively as the “parties”.
COLLABORATION AGREEMENTCollaboration Agreement • December 18th, 2020 • Panacea Acquisition Corp • Pharmaceutical preparations • California
This Collaboration Agreement (this “Agreement”), dated January 21, 2019 (the “Effective Date”), is by and between RePharmation Inc., a Delaware corporation (“Customer”), RePharmation Limited, a Bermuda company (“Limited”), and SPARCBIO LLC, a Delaware limited liability company (“Consultant”).
Re: Offer Letter for Chief Financial OfficerOffer Letter • December 18th, 2020 • Panacea Acquisition Corp • Pharmaceutical preparations
Nuvation Bio Inc. (the “Company”) is pleased to offer you the position of Chief Financial Officer on the terms set forth in this letter agreement (the “Agreement”).
